<?xml version="1.0" ?>
<document id="9bad9c5864165815b35dd2c78cd0ed7b285f0517">
  <chunk id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c0" text="Receptor Binding Domain Based HIV Vaccines"/>
  <chunk id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1" text="This paper analyzes the main trend of the development of acquired immunodeficiency syndrome (AIDS) vaccines in recent years. Designing an HIV-1 vaccine that provides robust protection from HIV-1 infection remains a challenge despite many years of effort. Therefore, we describe the receptor binding domain of gp120 as a target for developing AIDS vaccines. And we recommend some measures that could induce efficiently and produce cross-reactive neutralizing antibodies with high binding affinity. Those measures may offer a new way of the research and development of the potent and broad AIDS vaccines.">
    <entity charOffset="57-91" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e0" ontology_id="DOID_635" text="acquired immunodeficiency syndrome" type="disease"/>
    <entity charOffset="66-91" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e1" ontology_id="DOID_612" text="immunodeficiency syndrome" type="disease"/>
    <entity charOffset="83-91" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e2" ontology_id="DOID_225" text="syndrome" type="disease"/>
    <entity charOffset="93-97" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e3" ontology_id="DOID_635" text="AIDS" type="disease"/>
    <entity charOffset="342-346" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e4" ontology_id="DOID_635" text="AIDS" type="disease"/>
    <entity charOffset="588-592" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e5" ontology_id="DOID_635" text="AIDS" type="disease"/>
  </chunk>
</document>
